EMEA-003360-PIP01-22 - paediatric investigation plan

tozorakimab

Key facts

• Active substance:
  tozorakimab
• Therapeutic area:
  Infections and infestations
• Decision number:
  P/0144/2024
• PIP number:
  EMEA-003360-PIP01-22
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of severe viral lower respiratory tract disease
• Route(s) of administration:
  Intravenous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  06/05/2024
• Compliance check done:
  Non

Decision

P/0144/2024: EMA decision of May 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral for tozorakimab (EMEA-003360-PIP01-22)

Reference Number: EMA/148128/2024